• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 78 of 100
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
HealthA Federal Judge Dismissed More Than 300 Lawsuits Against Pfizer
By Sy MukherjeeApril 7, 2016
Losses mount for U.S. stocks.
FinanceThis Pharma Company’s Stock Is Popping for No Clear Reason
By Sy MukherjeeApril 7, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthCancer Treatment Costs Aren’t Rising as Fast as You Thought
By Laura LorenzettiApril 6, 2016
Over 400 Marijuana Stores Ordered To Close As City Regulates Industry
RetailThe DEA Will Soon Decide Whether it Will Reschedule Marijuana
By Tom Huddleston Jr.April 6, 2016
External Insulin Pump
HealthLifesaving Diabetes Drug Price Tripled in 10 Years
By TIME and Alexandra SifferlinApril 6, 2016
Inside of a Gilead Sciences Lab
HealthThe FDA Just Approved Another Next-Gen Gilead HIV Drug
By Sy MukherjeeApril 5, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceThis Is Why Valeant’s Shares Are Soaring
By Lucinda ShenApril 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthSex Doesn’t Sell: Valeant Cutting Its ‘Female Viagra’ Sales Force
By ReutersApril 5, 2016
DNA genetic testing (crop)
HealthGlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
HealthMakers Took Big Price Increases on Widely Used U.S. Drugs
By ReutersApril 4, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
HealthSamsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
HealthNovartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
Doctors Without Borders Protests High Cost Of Vaccines
FinancePfizer Just Got Pranked Big Time Before April Fool’s Day Even Started
By Jen WiecznerMarch 31, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Can’t Sell Valeant Even If He Wants To
By Lucinda ShenMarch 31, 2016
483106863
HealthGlaxoSmithKline Is Expanding Drug Access to the World’s Poorest Countries
By Sy MukherjeeMarch 31, 2016
1...
  • 76
  • 77
  • 78
  • 79
  • 80
...100
Most Popular
Commentary
Ray Dalio: I've studied 500 years of history and fear we're entering the most dangerous phase of the 'Big Cycle'An image of a popular article
By Ray DalioMarch 14, 2026
Politics
After 93 years and a 25-hour filibuster, Washington finally has an income tax, and billionaires are already packing their bagsAn image of a popular article
By Catherina GioinoMarch 15, 2026
Workplace Culture
Gen Z is dating less. The result is one of the most unprepared workforcesAn image of a popular article
By Jake AngeloMarch 15, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.